You are right. The FMV figure will ajust itself when revenue hits. We are much better off than we were one month ago, six months ago, over two years ago! The pipeline has matured to a point where if you can't see revenue coming then you don't get it. Sure it's taking a little longer but, I'm investing for the long term so no rush for me. Just get the science right and put the intlectual property on lockdown and let's go. What really makes me smile are the giant leaps and bounds being made in the pipeline. This is not the white knuckle investment it was years ago way under a penny. Sure we have many, many new shares. I get that. You may call it dilution, I call it dilution with value. The many new additions to the pipeline, BOD, BOA, and the unknowns at this point, would have never been possible without new shares.
Thanks for the cheap shares today. My 2015 Roth investment went all AMBS today. Another 73k on the pile.
Long & $torng AMBS
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links